J. Sturgess

Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification.

J. O’Keefe, C. Lavie, Sanjaya K. Gupta, 2021, The American journal of cardiology.

Takotsubo Syndrome: Cardiotoxic Stress in the COVID Era

J. O’Keefe, C. Lavie, K. Bybee, 2020, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism.

J. Lieberman, J. Kennedy, D. Müller, 2012, Genetic testing and molecular biomarkers.

Safety and efficacy of long-term treatment with inhaled beclomethasone dipropionate in steroid-dependent asthma.

S. Tarlo, P. Corey, A. Leznoff, 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Pharmacogenetics of alcohol, nicotine and drug addiction treatments

A. Heinz, J. Kennedy, T. George, 2011, Addiction biology.

Physicians' opinions following pharmacogenetic testing for psychotropic medication

J. Kennedy, D. Müller, E. Brandl, 2015, Psychiatry Research.

Pharmacogenetics of antipsychotic treatment response and side effects.

D. Müller, O. Likhodi, J. Sturgess, 2010, Therapy.

Adenosine A1 and A2A receptors are not upstream of caffeine’s dopamine D2 receptor‐dependent aversive effects and dopamine‐independent rewarding effects

D. van der Kooy, J. Sturgess, D. Podbielski, 2010, The European journal of neuroscience.

A test of the opponent‐process theory of motivation using lesions that selectively block morphine reward

D. van der Kooy, A. Heinmiller, Hector Vargas-Perez, 2007, The European journal of neuroscience.

Adenosine A1 and A2A receptors are not upstream of caffeine’s dopamine D2 receptor‐dependent aversive effects and dopamine‐independent rewarding effects

D. van der Kooy, J. Sturgess, D. Podbielski, 2010, The European journal of neuroscience.